Zagreb, Croatia

Amalija Narandja



Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1997-2003

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Amalija Narandja: Innovator in Pharmaceutical Chemistry

Introduction

Amalija Narandja is a prominent inventor based in Zagreb, Croatia. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on various compounds and their derivatives. With a total of six patents to her name, Narandja has established herself as a key figure in the development of new pharmaceutical products.

Latest Patents

Among her latest patents is the invention related to 3-deoxy-desmycosin derivatives and the process for their preparation. This invention involves derivatives of 3-deoxy desmycosin, where specific chemical reactions are performed to create new compounds. Another notable patent focuses on hydroxy derivatives of tylosin and the process for their preparation. This invention introduces 12,13-dihydroxy derivatives of tylosin, which are new semisynthetic compounds of the macrolide class, showcasing her expertise in creating innovative pharmaceutical solutions.

Career Highlights

Throughout her career, Narandja has worked with several notable companies, including Pliva, Farmaceutska Industrija, and Kemijska, Prehrambena i Kozmetička Industrija. Her experience in these organizations has allowed her to refine her skills and contribute to various projects that advance pharmaceutical research and development.

Collaborations

Amalija has collaborated with several professionals in her field, including Nevenka Lopotar and Marko Djerek. These collaborations have further enriched her work and have led to the successful development of her patented inventions.

Conclusion

Amalija Narandja's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her importance in the field. Her work continues to influence the development of new pharmaceutical compounds, making her a significant figure in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…